GoodRx Holdings, Inc. (GDRX) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
GoodRx Holdings, Inc. (GDRX) Bundle
Enhance your investment strategies with the (GDRX) DCF Calculator! Utilize actual GoodRx financial data, adjust growth predictions and expenses, and observe the immediate effects of these changes on the intrinsic value of (GDRX).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 388.2 | 550.7 | 745.4 | 766.6 | 750.3 | 896.4 | 1,071.0 | 1,279.7 | 1,529.0 | 1,826.8 |
| Revenue Growth, % | 0 | 41.85 | 35.36 | 2.83 | -2.12 | 19.48 | 19.48 | 19.48 | 19.48 | 19.48 |
| EBITDA | 148.3 | -257.1 | 48.0 | 68.5 | 112.9 | 39.3 | 47.0 | 56.1 | 67.1 | 80.1 |
| EBITDA, % | 38.19 | -46.69 | 6.44 | 8.94 | 15.05 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 |
| Depreciation | 15.7 | 22.9 | 37.6 | 57.5 | 107.7 | 63.0 | 75.2 | 89.9 | 107.4 | 128.3 |
| Depreciation, % | 4.05 | 4.16 | 5.05 | 7.5 | 14.35 | 7.02 | 7.02 | 7.02 | 7.02 | 7.02 |
| EBIT | 132.5 | -280.0 | 10.4 | 11.0 | 5.3 | -23.6 | -28.2 | -33.7 | -40.3 | -48.1 |
| EBIT, % | 34.14 | -50.85 | 1.39 | 1.44 | 0.70109 | -2.64 | -2.64 | -2.64 | -2.64 | -2.64 |
| Total Cash | 26.1 | 968.7 | 941.1 | 757.2 | 672.3 | 708.3 | 846.3 | 1,011.2 | 1,208.2 | 1,443.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 48.1 | 68.7 | 126.4 | 117.1 | 160.0 | 140.6 | 168.0 | 200.8 | 239.9 | 286.6 |
| Account Receivables, % | 12.4 | 12.48 | 16.96 | 15.28 | 21.33 | 15.69 | 15.69 | 15.69 | 15.69 | 15.69 |
| Inventories | .0 | 2.9 | -8.3 | .0 | .0 | -1.1 | -1.3 | -1.5 | -1.8 | -2.2 |
| Inventories, % | 0.000000258 | 0.5266 | -1.12 | 0 | 0 | -0.1182 | -0.1182 | -0.1182 | -0.1182 | -0.1182 |
| Accounts Payable | 7.9 | 10.3 | 17.5 | 17.7 | 36.3 | 24.0 | 28.7 | 34.2 | 40.9 | 48.9 |
| Accounts Payable, % | 2.02 | 1.87 | 2.35 | 2.31 | 4.83 | 2.68 | 2.68 | 2.68 | 2.68 | 2.68 |
| Capital Expenditure | -5.7 | -35.8 | -34.5 | -55.2 | -55.8 | -48.8 | -58.4 | -69.7 | -83.3 | -99.5 |
| Capital Expenditure, % | -1.48 | -6.51 | -4.62 | -7.2 | -7.43 | -5.45 | -5.45 | -5.45 | -5.45 | -5.45 |
| Tax Rate, % | 84.04 | 84.04 | 84.04 | 84.04 | 84.04 | 84.04 | 84.04 | 84.04 | 84.04 | 84.04 |
| EBITAT | 105.5 | -270.9 | 25.7 | 15.6 | .8 | -18.5 | -22.1 | -26.5 | -31.6 | -37.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 75.2 | -304.9 | -10.3 | 19.0 | 28.4 | 3.8 | -27.8 | -33.2 | -39.7 | -47.4 |
| WACC, % | 9.75 | 10.12 | 10.19 | 10.19 | 8.36 | 9.73 | 9.73 | 9.73 | 9.73 | 9.73 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -102.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -48 | |||||||||
| Terminal Value | -626 | |||||||||
| Present Terminal Value | -394 | |||||||||
| Enterprise Value | -496 | |||||||||
| Net Debt | 39 | |||||||||
| Equity Value | -535 | |||||||||
| Diluted Shares Outstanding, MM | 410 | |||||||||
| Equity Value Per Share | -1.30 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real GDRX financials.
- Real-World Data: Historical data and forward-looking estimates (highlighted in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effect of your inputs on GoodRx's valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- 🔍 Real-Life GDRX Financials: Pre-filled historical and projected data for GoodRx Holdings, Inc. (GDRX).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate GoodRx’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize GoodRx’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Download the Template: Gain immediate access to the Excel-based GDRX DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates GoodRx's intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
- Analyze and Decide: Utilize the findings to inform your investment or financial analysis.
Why Choose This Calculator for GoodRx Holdings, Inc. (GDRX)?
- Comprehensive Tool: Features DCF, WACC, and financial ratio analyses all in one convenient package.
- Customizable Inputs: Modify the yellow-highlighted cells to explore various financial scenarios.
- Detailed Insights: Automatically computes the intrinsic value and Net Present Value for GoodRx Holdings, Inc. (GDRX).
- Preloaded Data: Access historical and forecasted data for accurate analysis starting points.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on GoodRx Holdings, Inc. (GDRX).
Who Should Use This Product?
- Investors: Accurately estimate GoodRx Holdings, Inc.’s (GDRX) fair value before making investment decisions.
- CFOs: Leverage a professional-grade DCF model for financial reporting and analysis specific to GoodRx Holdings, Inc. (GDRX).
- Consultants: Quickly adapt the template for valuation reports tailored for GoodRx Holdings, Inc. (GDRX) clients.
- Entrepreneurs: Gain insights into financial modeling techniques utilized by leading companies like GoodRx Holdings, Inc. (GDRX).
- Educators: Use it as a teaching tool to demonstrate valuation methodologies applicable to GoodRx Holdings, Inc. (GDRX).
What the Template Contains
- Historical Data: Includes GoodRx's past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate GoodRx's intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of GoodRx's financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.